Protect the unvaccinated, then offer boosters – WHO’s Ryan

DUBLIN: Getting an initial course of Covid-19 vaccines to unprotected groups all over the world should remain a top priority before offering booster shots to vulnerable groups, World Health Organisation (WHO) Emergency Director Mike Ryan said on Tuesday.

A major study on Tuesday found that two doses of Pfizer-BioNTech’s Covid-19 vaccine appear to have given 70% protection against hospitalisation in South Africa in recent weeks, suggesting weaker efficacy against the new Omicron variant.

Ryan said he expected the current vaccines would provide significant protection against hospitalisation and death, but that the data coming through was very preliminary and the WHO did not have enough of it yet to make a full determination.

“People are always asking should we be going for a primary vaccination or boosters, the reality is we should be doing both,” Ryan told an online event.

“We should be focusing on getting those who are unvaccinated vaccinated as quickly as possible and then being able to give booster doses to those in vulnerable groups.”

Ryan said Omicron would most likely replace Delta as the globally dominant variant over time and that governments needed to refocus on basic protective measures such as mask wearing and make sure their hospitals were ready.

Even if Omicron turns out to be a milder disease in an individual patient, there was no doubt that the rapidly rising force of infection would generate more hospitalisations in the coming weeks just by the sheer weight of numbers, he added.

“Every single health system needs to get ready,” Ryan said. “We are going to likely to see a very large Omicron wave. We need to protect the health system, we need to protect those we love. It’s not rocket science, everyone knows how to do it.”

  • Related Posts

    • Pharma
    • December 23, 2024
    • 107 views
    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

    • Pharma
    • December 23, 2024
    • 132 views
    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt